(Q46359594)
Statements
1 reference
A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America (English)
1 reference
Marc Gittelman
1 reference
Peter J Pommerville
1 reference
Bo-Eric Persson
1 reference
Jens-Kristian Jensen
1 reference
Tine Kold Olesen
1 reference
Degarelix Study Group
1 reference
17 September 2008
1 reference
1 reference
180
1 reference
5
1 reference
1986-1992
1 reference